Skip to content

Percutaneous Endoscopic Biliary Exploration in Complex Biliary Stone Disease

Percutaneous Endoscopic Biliary Exploration in Complex Biliary Stone Disease: Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04308993
Enrollment
15
Registered
2020-03-16
Start date
1999-01-01
Completion date
2019-08-19
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Stones

Brief summary

Patients with complex biliary stone disease are challenging to treat. The investigator present their experience in using urological interventions to treat challenging biliary stones. Methods: Fifteen patients with biliary calculi underwent 21 interventions using either extracorporeal shock wave lithotripsy (ESWL), percutaneous transhepatic choledochoscopy, percutaneous transcystic choledochoscopy, or a combination of these.

Detailed description

The investigator conducted a retrospective review to investigate the outcomes of urological treatments for biliary calculi from January 1, 1999, to August 31, 2016, focusing on percutaneous endoscopic methods and/or ESWL. The primary outcomes of interest were symptom- and stone-free rates, length of hospital stay, and complications. Our institutional ethics review board approved the study (IRB-2018-01-119). Due to the retrospective nature of the study, the need for informed consent was waived. One endourologist evaluated all patients preoperatively. Urological intervention techniques The three different approaches used (ESWL, PTHC, and PTCC) are described below.

Interventions

PROCEDUREpercutaneous transhepatic choledochoscopy

percutaneous transhepatic choledochoscopy

Sponsors

Imam Abdulrahman Bin Faisal University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* complete records

Exclusion criteria

* lost follow up

Design outcomes

Primary

MeasureTime frameDescription
symptomsat least one year follow upsuccess rate of biliary stone clearance or asymptomatic derbies

Secondary

MeasureTime frameDescription
ultrasoundone monthevidence of stone clearance

Other

MeasureTime frameDescription
obstructive jaundiceone daybiochemical evidence (Liver function test) of improvement

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026